The role of metabolites in valproic acid (VPA)-associated hepatotoxicity was studied in rats. The most steatogenic mono-unsaturated metabolite, 4-en-VPA, caused the greatest changes in indicators of beta-oxidation inhibition (dicarboxylic aciduria, beta-hydroxybutyrate reduction); however, the bioch
Variability of pharmacokinetic parameters of valproic acid and two of its metabolites
✍ Scribed by J. Darius; U. Tröger; F.P. Meyer
- Book ID
- 119179445
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 136 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1043-6618
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The pharmacokinetics of the following two polyesteric prodrugs of valproic acid (VPA) have been investigated: 1,4‐butanediol divaiproate (BDV) and glyceryl trivalproate (GTV). In addition, the anticonvulsant activity of these compounds has been evaluated and compared to that of VPA and
## Abstract Human therapeutic valproic acid (VPA) levels could be maintained in the mouse for a period of 1 week by constant rate application via subcutaneously implanted osmotic minipumps. Also, the concentrations of VPA metabolites observed in mouse plasma were similar to those seen in human plas